Masimo Corp at Needham Healthcare Conference Transcript
All right. So good afternoon, everyone. I'm Mike Matson, medical device analyst here at Needham & Company. I'm pleased to introduce Masimo. Up on stage, we have Todd Koning. He is Senior Vice President of Finance. And sitting over there, we have Eli Kammerman. He is Vice President, Business Development and Investor Relations. So we're going to be doing a fireside chat here today.
Questions & Answers
So I'm -- kind of broke it out by your different kind of product lines and then some other more general questions. So I guess, I just wanted to start with your SET measurements. So can you talk about whether or not you're still capturing share in the core oximetry market? And if so, what's allowing you to capture that share?
Yes, yes. Well, first off, thanks, Mike for having us. We're really pleased to be here and share our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |